Testosterone Cypionate by Qualgen LLC

Testosterone Cypionate by

Drug Labeling and Warnings

Testosterone Cypionate by is a Prescription medication manufactured, distributed, or labeled by Qualgen LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

TESTOSTERONE CYPIONATE- testosterone cypionate solution 
Qualgen LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

TESTOSTERONE CYPIONATE
IM or SQ Injection

Contains (per vial):
Testosterone Cypionate 2g,
Benzyl Benzoate 2mL,
Benzyl Alcohol 0.9mL and
Grapeseed Oil

NDC: 69761-312-11

10 mL Multi-Dose Vial

TESTOSTERONE CYPIONATE
IM or SQ Injection

200 mg/mL

This is a
compounded
drug.

Qualgen | 14844 Bristol Park Blvd., Edmond, OK 73013 | ph: 405-551-8216

res

TESTOSTERONE CYPIONATE 
testosterone cypionate solution

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 69761-312
Route of Administration	INTRAMUSCULAR	DEA Schedule	CIII

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TESTOSTERONE CYPIONATE (UNII: M0XW1UBI14) (TESTOSTERONE - UNII:3XMK78S47O)	TESTOSTERONE CYPIONATE	200 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
BENZYL BENZOATE (UNII: N863NB338G)
BENZYL ALCOHOL (UNII: LKG8494WBH)
GRAPE SEED OIL (UNII: 930MLC8XGG)

Product Characteristics
Color	yellow (Clear pale yellow)	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 69761-312-11	1 in 1 BOX	01/02/2021
1		10 mL in 1 VIAL, GLASS; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		01/02/2021	10/04/2021

Labeler - Qualgen LLC (034474862)

Revised: 9/2021

Document Id: cd00f95e-491f-3610-e053-2a95a90af00d

34391-3

Set id: ea4b0991-afe1-40c1-ad62-5eed4d52cccb

Version: 2

Effective Time: 20210927